Letter from Scientific Affairs Chair

Troy Varenchik, Director of Scientific Affairs

I am proud to be the Director of the Pediatric Cancer Research Foundation Scientific Affairs Committee. This Committee shapes the direction of funding provided by PCRF and ensures the integrity of the review process for awarding grants. This is an exciting time for PCRF, as we are accepting new grant requests starting January 1, 2017 through May 1, 2017. PCRF’s Scientific Review Committee (“SRC”) is comprised of eight leading doctors from the pediatric cancer research community nationwide. The SCR assists in identifying new developments in research that merit further study. Grants are then scored based on specific review criteria, and recommendations for awards based on scientific merit is given to the PCRF Board of Directors.

PCRF currently funds some of the best and most advanced pediatric cancer research in the areas of Stem Cell Transplantation, Stem Cell Biology, Molecular Oncology, Local immune suppression in solid tumors, and Molecular and Cellular Genetics. Funding we are providing in 2016 supports research to find a cure for specific pediatric cancers including but not limited to Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Gliomas, Medulloblastoma, and Ewing Sarcoma.

The researchers we are funding in 2016 practice at some of the most well recognized hospitals in the U.S., including New York Medical College, Mattel Children’s Hospital UCLA, Penn State College of Medicine, Emory University, Dana Farber Cancer Institute in Boston, Seattle Children’s Research Institute, University of Utah, and Children’s Hospital Los Angeles. Since awarding our first grants in 1982, PCRF has grown through 34 years of funding research to save children’s lives, awarding over $36 million to 122 different grant proposals. The research we’ve invested in has enabled significant advances across the research spectrum, improving the care, quality of life, and survival rate of children with malignant diseases. Learn more about our funded doctors and what they’re doing to change the future of pediatric cancer treatment, care and prevention: Research.

For children battling for their lives, every discovery offers new hope. Our grant program is a vital source of support for the scientific effort to build our knowledge base and conquer this disease. We will continue to fund the best research in the U.S. and welcome applications proposing novel approaches to the prevention, management and cure of pediatric cancer.

Join us to find a cure,

Troy Varenchik
Scientific Affairs Chair